Denosumab Approved by FDA for Giant-Cell Tumor of the Bone

The first treatment for a rare tumor called giant-cell tumor of the bone has been approved by FDA. The approval of denosumab (Xgeva) was based on a priority FDA review.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news